SK Hynix Gives Up Previous Day's Gains in One Day... Semiconductor Stocks Weaken Amid US-Iran Tensions
SK Hynix (000660) showed a sharp decline early in the trading session on the 24th, losing the 1.9 million won level it had recovered the previous day. As geopol

SK Hynix (000660) showed a sharp decline early in the trading session on the 24th, losing the 1.9 million won level it had recovered the previous day. As geopolitical tensions between the United States and Iran escalated, the broader domestic stock market turned bearish, and profit-taking sell orders poured into large-cap semiconductor stocks.
As of 9:48 a.m. on the 24th, SK Hynix is trading at 1,831,000 won, down 88,000 won (4.59%) from the previous trading day. The stock had reclaimed the 1.9 million won level on the strength of the previous day's rally, but reversed downward in just one day, surrendering all of its gains.
At the same time, the KOSPI fell by 228.53 points (3.22%) to 6,868.36, and the KOSDAQ dropped by 21.94 points (2.77%) to 768.34, with both major indices showing simultaneous weakness.
The rising tensions between the U.S. and Iran are cited as a burden on the stock market. In an interview with the U.S. online media outlet Axios on the 23rd (local time), U.S. President Donald Trump indicated regarding Iran that he is considering an attack on a much larger scale than before, and that he is on the verge of making a decision with all preparations complete.
The expansion of geopolitical risks could act as additional downward pressure on the stock market, as it could resurface concerns over rising international oil prices and inflation. In particular, profit-taking sell orders flowed in, centering on large-cap stocks including semiconductor shares, increasing stock price volatility.
Investors are closely watching future developments in the Middle East situation, international oil price trends, U.S. interest rate outlook, and the global semiconductor industry cycle, focusing their attention on the possibility of a rebound for SK Hynix.
[※ This article is provided as reference material for investment decisions and does not recommend the purchase or sale of any specific stock. The responsibility for investment lies with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Hyundai Pharmaceutical Surges 13% Despite VI Trigger... 'Bucking the Trend' Amid KOSPI and KOSDAQ Plunge](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F07%2F587618%2F6d706435189d6b28%2Fvariants%2Fhero.webp&w=1920&q=75)


